logo-loader
AMEX:CVM

CEL-SCI Corporation

Receive alerts
Market:
AMEX
Market Cap:
$458.76 m
Price
12.19 USD
Change
-10.24%
52 weeks high
18.00
52 weeks low
3.70

In brief

CEL-SCI Corporation (CEL-SCI) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.